|Bid||0.00 x 1100|
|Ask||0.00 x 1000|
|Day's range||33.73 - 36.47|
|52-week range||13.84 - 62.49|
|Beta (5Y monthly)||0.08|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||13 Dec 2012|
|1y target est||N/A|
Shares of Cassava are moving higher on news that its rival Roche suffered a setback in its Alzheimer's drug research trial.
Cassava Sciences (SAVA) is expected to provide an update on its pipeline candidates during its third-quarter earnings.
Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $36.44, moving -0.87% from the previous trading session.